Recent events
Recent events tied to this brand in public sources.
Back to profile1 entries
2020
CSRC opens investigation into Tianmu Pharmaceutical
Tianmu Pharmaceutical said it received a China Securities Regulatory Commission investigation notice on April 21. The regulator decided to investigate the company over suspected violations involving information disclosure. The article also reports allegations concerning undisclosed related-party guarantees and loans.